Literature DB >> 33707844

Clinical Profile and Severity of Hemolysis in Adult Patients of Primary Autoimmune Hemolytic Anemia and Their Response to Steroid: A Prospective Cohort Study from Single Institution.

Gopal Krushna Ray1, Debasish Mishra1, Rabindra Kumar Jena2, Smita Mahapatra1, Sabita Palai1, Ansuman Abhishek Parida3.   

Abstract

Autoimmune hemolytic anaemia (AIHA) has traditionally been classified based on the temperature sensitivity of the autoagglutinins as warm (WAIHA), cold (CAIHA) and mixed type. Autoagglutinin may be of IgG or IgM type. The present prospective study was conducted to evaluate the profile of clinical picture, severity of haemolysis, treatment response of steroid. This study on patients of adult primary AIHA was conducted by taking complete history followed by detail physical examination. Laboratory investigations were performed to establish haemolytic anaemia and to assess severity of haemolysis. Immunehematological work up including blood grouping, direct antiglobulin test (DAT), IAT, antibody screening, adsorption elution was performed to diagnose type of AIHA. All cases were followed up to assess the response to prednisolone. All the data were collected and analysed by SPSS 19. Out of 62 primary AIHA cases, female were affected more than male (41:21). WAIHA is most common type (42, 67.8%) followed by mixed (20.9%) and cold AIHA (11.3%). Severity of haemolysis showed significant correlation with the DAT strength and not with type of AIHA. (P < 0.05) On oral prednisolone, 22 cases attended complete remission, while relapse, drug dependency and partial remission was achieved in 13, 9, 3 cases respectively. Severity of haemolysis in AIHA is directly related with DAT strength. WAIHA is most common type and can be managed with oral prednisolone (cr 45.2%), without red cell transfusion in most of cases. Mixed type AIHA cases were presented mostly with severe haemolysis, with minimum therapeutic response to prednisolone and maximum relapse/drug dependency. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  Autoantibody; Direct antiglobulin test; Immunohematology; Mixed-AIHA

Year:  2020        PMID: 33707844      PMCID: PMC7900313          DOI: 10.1007/s12288-020-01326-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  15 in total

1.  Clinical aspects of autoimmune hemolytic anemia.

Authors:  B Pirofsky
Journal:  Semin Hematol       Date:  1976-10       Impact factor: 3.851

2.  A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Authors:  Henrik Birgens; Henrik Frederiksen; Hans C Hasselbalch; Inge H Rasmussen; Ove J Nielsen; Lars Kjeldsen; Herdis Larsen; Torben Mourits-Andersen; Torben Plesner; Dorthe Rønnov-Jessen; Hanne Vestergaard; Tobias W Klausen; Claudia Schöllkopf
Journal:  Br J Haematol       Date:  2013-08-24       Impact factor: 6.998

Review 3.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  How I treat autoimmune hemolytic anemias in adults.

Authors:  Klaus Lechner; Ulrich Jäger
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

5.  Corticosteroid effect on immunoglobulins.

Authors:  G A Settipane; R K Pudupakkam; J H McGowan
Journal:  J Allergy Clin Immunol       Date:  1978-09       Impact factor: 10.793

6.  Low-titer cold-hemagglutinin disease. Mechanism of hemolysis and response to corticosteroids.

Authors:  A D Schreiber; B S Herskovitz; M Goldwein
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

7.  Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965.

Authors:  J W Allgood; H Chaplin
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

Review 8.  Hemolytic anemia due to warm autoantibodies.

Authors:  Charles H Packman
Journal:  Blood Rev       Date:  2007-09-27       Impact factor: 8.250

9.  Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India.

Authors:  Sudipta Sekhar Das; Soniya Nityanand; Rajendra Chaudhary
Journal:  Ann Hematol       Date:  2009-01-03       Impact factor: 3.673

10.  Incompatible blood transfusion: Challenging yet lifesaving in the management of acute severe autoimmune hemolytic anemia.

Authors:  Sudipta Sekhar Das; Rafiq Uz Zaman; Mohammad Safi
Journal:  Asian J Transfus Sci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.